We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advisory Committee Votes Against Genasense
FDA Advisory Committee Votes Against Genasense
September 8, 2006
The FDA’s Oncologic Drugs Advisory Committee Sept. 6 recommended against approving Genta’s new drug application (NDA) for Genasense.